Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ.
Int J Audiol
; 53(8): 564-76, 2014 Aug.
Article
en En
| MEDLINE
| ID: mdl-25005776
ABSTRACT
OBJECTIVE:
This paper provides a detailed description of the Nucleus 6 system, and clinically evaluates user performance compared to the previous Nucleus 5 system in cochlear implant recipients. Additionally, it clinically evaluates a range of Nucleus 6 and Nucleus 5 programs to determine the performance benefits provided by new input processing technologies available in SmartSound iQ.DESIGN:
Speech understanding tests were used to clinically validate the default Nucleus 6 program, by comparing performance outcomes against up to five custom Nucleus 5 or Nucleus 6 programs in a range of listening environments. Clinical comparisons between programs were conducted across the following listening environments; quiet, speech weighted noise (co-located and spatially separated noise), and 4-talker babble (co-located and spatially separated noise). STUDY SAMPLE Twenty-one adult cochlear implant recipients participated.RESULTS:
Significant speech understanding benefits were found with the default Nucleus 6 program compared to the participants' preferred program using their Nucleus 5 processor and compared to a range of custom Nucleus 6 programs. All participants successfully accepted and upgraded to the new default Nucleus 6 SmartSound iQ program.CONCLUSION:
This study demonstrates the acceptance and clinical benefits of the Nucleus 6 cochlear implant system and SmartSound iQ.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Percepción del Habla
/
Implantes Cocleares
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2014
Tipo del documento:
Article